E
Elicio Therapeutics, Inc. ELTX
$8.87 -$0.20-2.21% NASDAQ
Recommendation
Prev Close
$8.87
Volume
146,155
Avg Vol (90D)
89,191
Market Cap
$144.79M
Dividend & Yield
--
52-Week Range
$4.60 - $12.62
P/E (TTM)
--
EPS (TTM)
-$3.94
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Elicio Therapeutics (ELTX, $8.87) Aroon Indicator entered a Downtrend on November 07, 2025.
11/8/2025 - Tickeron - Stocks
Elicio Therapeutics: Running On Fumes, But A Definitive Readout Appears Imminent
11/7/2025 - Seeking Alpha - Long Ideas
Elicio Therapeutics (ELTX) Reveals Promising Data from Cancer Trials
11/7/2025 - GuruFocus
Elicio Therapeutics announces additional data from Phase 2 AMPLIFY-7P trial
11/7/2025 - The Fly
Elicio Therapeutics Reports Robust, Cytolytic mKRAS-Specific T Cell Responses Across Diverse ...
11/7/2025 - GuruFocus
Elicio Therapeutics Reports Robust, Cytolytic mKRAS-Specific T Cell Responses Across Diverse Patient HLA in Ongoing Phase 2 AMPLIFY-7P Trial of ELI-002 7P and New ELI-004 Preclinical Data at SITC
11/7/2025 - Globe Newswire
Elicio Therapeutics (ELTX, $9.07) Aroon Indicator entered a Downtrend on November 06, 2025.
11/7/2025 - Tickeron - Stocks
Elicio Therapeutics (ELTX, $9.07) RSI Indicator left the oversold zone on November 06, 2025
11/7/2025 - Tickeron - Stocks
Elicio Therapeutics (ELTX, $9.13) Aroon Indicator entered a Downtrend on November 05, 2025.
11/6/2025 - Tickeron - Stocks
Elicio Therapeutics (ELTX, $9.15) Aroon Indicator entered a Downtrend on November 04, 2025.
11/5/2025 - Tickeron - Stocks
Elicio Therapeutics (ELTX, $9.25) Aroon Indicator entered a Downtrend on November 03, 2025.
11/4/2025 - Tickeron - Stocks
Elicio Therapeutics to Present Clinical and Preclinical Data at the SITC 2025 Annual Meeting
11/3/2025 - GuruFocus
Elicio Therapeutics to Present Clinical and Preclinical Data at the SITC 2025 Annual Meeting
11/3/2025 - Globe Newswire
Elicio Therapeutics (ELTX, $9.4) Stochastic Oscillator left the oversold zone on October 29, 2025
10/30/2025 - Tickeron - Stocks
Elicio Therapeutics (ELTX, $9.74) Stochastic Oscillator left the oversold zone on October 28, 2025
10/29/2025 - Tickeron - Stocks
Elicio Therapeutics (ELTX) Highlights Genetic Diversity in Phase 2 Trial
10/27/2025 - GuruFocus
Elicio Therapeutics Reports Robust T cell Responses Across Diverse HLA backgrounds in Ongoing ...
10/27/2025 - GuruFocus
Elicio Therapeutics Reports Robust T cell Responses Across Diverse HLA backgrounds in Ongoing Phase 2 AMPLIFY-7P Trial
10/27/2025 - Globe Newswire
Elicio Therapeutics (ELTX, $9.7) Aroon Indicator entered a Downtrend on October 24, 2025.
10/25/2025 - Tickeron - Stocks
Elicio Therapeutics (ELTX, $9.5) Aroon Indicator entered a Downtrend on October 23, 2025.
10/24/2025 - Tickeron - Stocks
Elicio Therapeutics (ELTX, $9.84) Aroon Indicator entered a Downtrend on October 22, 2025.
10/23/2025 - Tickeron - Stocks
Elicio Therapeutics (ELTX, $9.84) RSI Indicator left the oversold zone on October 22, 2025
10/23/2025 - Tickeron - Stocks
Elicio Therapeutics (ELTX, $9.47) Aroon Indicator entered a Downtrend on October 21, 2025.
10/22/2025 - Tickeron - Stocks
Elicio Therapeutics (ELTX, $9.48) Aroon Indicator entered a Downtrend on October 20, 2025.
10/21/2025 - Tickeron - Stocks
Elicio Therapeutics (ELTX, $9.35) RSI Indicator left the oversold zone on October 17, 2025
10/18/2025 - Tickeron - Technical Analysis
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
-$44.38M
EBIT (TTM)
-$44.65M
Net Income (TTM)
-$54.61M
Balance Sheet
Total Assets (Q)
$29.53M
Total Debt (Q)
$14.90M
Total Liabilities (Q)
$27.69M
Book Value Per Share (Q)
$0.1128
Cash Flow
Cash from Operations (TTM)
-$35.09M
Cash from Investing (TTM)
-$45.00K
Cash from Financing (TTM)
$53.24M
Net Change in Cash (TTM)
$18.28M
Filings
Filing Date
Thursday, August 7, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Nov 10 and 14 (est)
Price History
Loading...
Beta
0.88
7-Day Total Return
-4.11%
30-Day Total Return
-18.17%
60-Day Total Return
-9.86%
90-Day Total Return
12.14%
Year to Date Total Return
72.57%
1-Year Total Return
74.61%
2-Year Total Return
22.34%
3-Year Total Return
--
5-Year Total Return
--
52-week Low
Apr 09, 2025 - $4.60
52-week High
Sep 17, 2025 - $12.62
Valuation
Market Cap
$144.79M - Micro Cap
Enterprise Value
$137.61M
Price/Sales (TTM)
--
Price/Book (Q)
78.63
Dividends and Shares
Shares Outstanding
16.06
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
elicio.com
Phone Number
857 209 0050
Address
451 D Street
5th Floor - Suite 501
Boston, MA 02210
Country
United States
Year Founded
--
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Elicio Therapeutics, Inc., a clinical-stage biotechnology company, develops immunotherapies for the treatment of cancer. Its lead product candidate is ELI-002, a multivalent lymph node–targeted... more
NASDAQ 11/07/2025 4:00PM Eastern Quotes delayed